December 2023 BCOP Test - Advances in Targeted Therapy for Biliary Tract Cancers |
|
02/28/2023 - 12:00am to 12/14/2024 - 11:59pm |
December 2023 BCOP Test - Updates in the Treatment of Adult Acute Lymphoblastic Leukemia |
|
02/28/2023 - 12:00am to 12/19/2024 - 11:59pm |
Evaluating Immune Checkpoint Inhibition Response Biomarkers |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia |
1.00 |
08/23/2023 - 12:00am to 08/23/2024 - 12:00am |
Immunotherapy in Hepatocellular Carcinoma: Improving the Treatment Paradigm Within Community Practice |
1.00 |
12/19/2023 - 12:00am to 12/19/2024 - 12:00am |
Incorporating Immunotherapeutic Strategies in the Management of Relapsed/Refractory Multiple Myeloma |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Individualized Multidisciplinary CLL/SLL Care: Practical Application of Guidelines and Emerging Data |
1.00 |
02/09/2024 - 12:00am to 02/09/2025 - 12:00am |
Integrative Medicine and the Cancer Patient |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Issues with Sexuality and Sexual Function in Patients with Breast Cancer |
1.00 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
June 2023 BCOP Test - Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma |
|
02/28/2023 - 12:00am to 06/28/2024 - 11:59pm |
Locoregional Management of Breast Cancer with SABCS Updates |
1.25 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
Management of Graft-Versus-Host Disease in Hematopoietic Cell Transplant Recipients |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Lower-Risk Myelodysplastic Syndromes |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies |
0.75 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |